# OnCo record prehevbrio (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/prehevbrio/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "prehevbrio" ;
  schema:name "PreHevbrio / PreHevbri (hepatitis B vaccine, adults, withdrawn)"@en ;
  schema:alternateName "PreHevbri"@en, "PreHevbrio" ;
  schema:description "VBI Vaccines' adult hepatitis B vaccine, licensed in the United States in 2021 and the European Union in 2022, and no longer marketed in either."@en ;
  schema:url <https://onco.cc/drugs/prehevbrio/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/PurpleBook/2026/purplebook-search-October-data-download.csv>, <https://www.ema.europa.eu/en/medicines/human/EPAR/prehevbri>, <https://www.who.int/news-room/fact-sheets/detail/hepatitis-b> ;
  onco:status "withdrawn" ;
  onco:tag "preventive-vaccine", "hepatitis-b-vaccine" ;
  onco:modality "Prophylactic vaccine (recombinant)" ;
  onco:approval "US 2021: Hepatitis B vaccine (recombinant), BLA 125737; discontinued", "EU 2022: Active immunisation against hepatitis B in adults (EMEA/H/C/005466); withdrawn" ;
  onco:related <https://onco.cc/drugs/heplisav-b/>, <https://onco.cc/drugs/engerix-b/> ;
  onco:sections <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:terms <https://onco.cc/terms/hbv-hcv/> .